Skip to main content

Human Recombinant Monoclonal NCAP antibody. Suitable for ELISA, WB and reacts with SARS-CoV-2 samples. Cited in 1 publication.

Be the first to review this product! Submit a review

Images

Western blot - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (AB283894), expandable thumbnail
  • ELISA - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (AB283894), expandable thumbnail

Publications

Key facts

Isotype
IgG1
Host species
Human
Storage buffer

pH: 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

Form
Liquid
Clonality
Monoclonal

Reactivity data

Select an application
Product promiseTestedExpectedPredictedNot recommended
ELISAWB
SARS-CoV-2
Tested
Tested

Tested
Tested

Species
SARS-CoV-2
Dilution info
0.1 µg/mL
Notes

-

Tested
Tested

Species
SARS-CoV-2
Dilution info
-
Notes

-

Associated Products

Select an associated product type

1 product for Alternative Version

Target data

Function

Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M (PubMed:33264373). Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Attenuates the stress granules formation by reducing host G3BP1 access to host mRNAs under stress conditions (PubMed:34901782, PubMed:36534661). May block host chemokine function in vivo, facilitating viral replication and transmission (PubMed:35921414). Acts by being secreted into the extracellular space where it competes to host chemokines for binding to host glycosaminoglycans (GAG) (PubMed:35921414). May induce inflammasome responses in cultured cells and mice. Acts by interacting with host NLRP3 to facilitate inflammasome assembly, which induces cytokine release that may play a role in COVID lung injury.

Alternative names

Nucleoprotein, N, Nucleocapsid protein, NC, Protein N

Recommended products

Human Recombinant Monoclonal NCAP antibody. Suitable for ELISA, WB and reacts with SARS-CoV-2 samples. Cited in 1 publication.

Key facts

Isotype
IgG1
Form
Liquid
Clonality
Monoclonal
Clone number
ABK79-E11
Purification technique
Affinity purification Protein A
Concentration
Loading...

Storage

Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Notes

This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The SARS-CoV-2 nucleocapsid protein also known as N protein plays a central role in the packaging and replication of the viral RNA genome. It functions mechanically by binding to the viral RNA to facilitate its replication and encapsidation. The nucleocapsid protein is expressed within the virus-infected cells particularly in the cytoplasm. It is a highly conserved structural protein of the virus and has a molecular weight of approximately 50 kDa. Additionally the nucleocapsid protein aids in RNA binding and is essential for the virus's structural stability.

Biological function summary

The nucleocapsid protein of SARS-CoV-2 is involved in maintaining the integrity of the viral genome. It forms a ribonucleoprotein complex with the viral RNA which is necessary for viral replication. The nucleocapsid protein is integral in the formation of the virus's structure and assists in the assembly and release of new virus particles. It interacts with other viral proteins contributing to the stability and functioning of the virus.

Pathways

The nucleocapsid protein is involved in the viral life cycle and replication pathways. The protein participates in the RNA replication and transcription complex working alongside proteins such as the RNA-dependent RNA polymerase and other non-structural proteins. These interactions within the pathways are essential for the efficient replication of the viral genome and production of new viral particles which are key steps in the virus's lifecycle.

Associated diseases and disorders

The nucleocapsid protein is directly linked to COVID-19 the disease caused by the SARS-CoV-2 virus. It is a target for various diagnostic tests such as the COVID ELISA test and corona IgA test due to its immunogenic properties. The presence of nucleocapsid antibodies in patients is often measured through tests like the ELISA test which helps in diagnosing COVID-19. The nucleocapsid protein's involvement in COVID-19 progression connects it with other viral proteins highlighting its significance in disease mechanisms and potential therapeutic targeting.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Western blot - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (ab283894), expandable thumbnail

    Western blot - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (ab283894)

    Lanes 1 - 2: Green - ab283894 observed at 51 kDa. ab283894 was shown to react with SARS-CoV-2 N-protein in Western blot. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab283894 overnight at 4 °C at a 1 in 1000 dilution. Blots were incubated with Goat anti-Human 800CW secondary antibody at 1 in 20000 dilution for 1 h at room temperature before imaging.

    All lanes: Western blot - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (ab283894)

    Lane 1: Western blot - Recombinant Human coronavirus SARS-CoV-2 nucleocapsid protein (His tag) (Recombinant Human coronavirus SARS-CoV-2 nucleocapsid protein (His tag) ab273530) at 0.2 µg

    Lane 2: Recombinant Human coronavirus SARS Nucleocapsid Protein at 0.2 µg

    Secondary

    All lanes: Goat anti-Human 800CW at 1/20000 dilution

  • ELISA - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (ab283894), expandable thumbnail

    ELISA - Anti-SARS-CoV-2 nucleocapsid protein antibody [ABK79-E11] (ab283894)

    Human monoclonal [ABK79-E11] to SARS-CoV-2 nucleocapsid protein (ab283894)
    Plates were coated with Recombinant Human coronavirus SARS-CoV-2 nucleocapsid protein (His tag, Recombinant Human coronavirus SARS-CoV-2 nucleocapsid protein (His tag) ab273530) at 1000 ng/ml.
    Primary antibody (ab283894) concentration range 0.045-100 ng/mL.
    Secondary antibody, Goat Anti-Human IgG Fc (HRP) preadsorbed (Goat Anti-Human IgG Fc (HRP) preadsorbed ab98624) used at 1/1000 dilution.

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com